Rhythm control and cardioversion

Sulke, N.; Sayers, F.; Lip, G. Y. H.
January 2007
Heart;Jan2007, Vol. 93 Issue 1, p29
Academic Journal
The article reports on cardioversion, rhythm control, and the treatment for paroxysmal atrial fibrillation. It states that the treatment aims to suppress paroxysms of atrial fibrillation and maintain long-term sinus rhythm, to control heart rate during paroxysms of atrial fibrillation if they occur, and to prevent the complications relative with paroxysmal atrial fibrillation such as stroke and tachycardia-induced cardiomyopathy.


Related Articles

  • Atrial Fibrillation: Defining Some Unanswered Questions. Singh, Bramah N.; Lopez, Becky // Journal of Cardiovascular Pharmacology & Therapeutics;Jun1998, Vol. 3 Issue 2, p195 

    The article offers information on atrial fibrillation (AF). As an arrythmia, it is many times more common than sustained ventricular tachycardia (VT) or fibrillation. AF is projected to grow as the life span in the U.S. as well as in industrialized countries continues to lengthen, thereby...

  • VENTRICULAR ACTIVITY DURING ATRIAL FIBRILLATION. Gavrilescu, Stefan; Luca, Constantin // Angiology;Nov1976, Vol. 27 Issue 11, p634 

    His bundle electrograms were recorded in 12 patients with atrial fibrillation. In all cases but one, the dominant rhythm was atrial fibrillation. In 1 case the dominant rhythm was fascicular tachycardia due probably to digitalis overdosage. However ventricular, fascicular and junctional beats...

  • NPC.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1600 

    An encyclopedia entry for "NPC" is presented, referring to the acronym for nodal premature complex.

  • HARMONY: Ranolazine, dronedarone combination reduced AF burden.  // Cardiology Today;Jun2014, Vol. 17 Issue 6, p1 

    The article reports on the reduction of atrial fibrillation (AF) in patients by the combination of ranolazine and dronedarone.

  • PERSPECTIVE. Milan, David // Cardiology Today;Jun2014, Vol. 17 Issue 6, p16 

    The author discusses the reduction of atrial fibrillation (AF) in patients by the combination of ranolazine and dronedarone.

  • Atrial Fibrillation.  // American Family Physician;7/15/2002, Vol. 66 Issue 2, p271 

    Presents information on atrial fibrillation. Clinical manifestations; Causes; Treatment.

  • ATRIAL FIBRILLATION: CLASSIFICATION, PATHOPHYSIOLOGY, MECHANISMS AND DRUG TREATMENT. Markides, Vias; Schilling, Richard J. // Heart;Aug2003, Vol. 89 Issue 8, p939 

    Details various aspects of the heart condition called atrial fibrillation (AF). Classification; Pathophysiology and mechanisms; Pharmacological treatment; Key points of AF management.

  • Atrial Fibrillation. McClellan, J. Mac // Flying;Aug99, Vol. 126 Issue 8, p86 

    Questions whether a person with a cardiac state of atrial fibrillation can be qualified for a third class medical certificate. Causes of atrial fibrillation; Medications.

  • Atrial fibrillation. Fernandes, Tanya // Nursing Standard;8/29/2012, Vol. 26 Issue 52, p58 

    A quiz on atrial fibrillation is presented.

  • Erratum to: Impact of hybrid procedure on P wave duration for atrial fibrillation ablation. Kumar, Narendra; Bonizzi, Pietro; Pison, Laurent; Phan, Kevin; Lankveld, Theo; Maesen, Bart; Meir, Mark; Gelsomino, Sandro; Maessen, Jos; Crijns, Harry // Journal of Interventional Cardiac Electrophysiology;Mar2015, Vol. 42 Issue 2, p171 

    A correction to the article "Impact of hybrid procedure on P wave duration for atrial fibrillation ablation," published in a previous issue is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics